Physicochemical Properties
Nov 11, 2025
•
5 min read
Why you should care about LogP
Sep 8, 2026
2 min read
Brain-Penetrant Covalent NLRP3 Inhibitor, Daraxonrasib Approval
PFAS in Drug Design, CNS-Penetrant KRAS G12C Inhibitor and More
Membrane permeable cyclic peptides, best practices for reporting ADME data
Dual E3 ligase degraders, resistance mechanisms to Daraxonrasib
Misconceptions for Medicinal Chemists🤔 300 Subscribers 🎉
What Happens in Successful Optimizations?📈Genentech’s Attempt at KRAS G12C💊 And More
